Characterization of monocyte subtypes in the allergic form of atopic eczema/dermatitis syndrome

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 10, 2002, Pages 931-935

  Novak, N ^a   Allam, P ^a   Geiger, E ^a   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Atopic eczema dermatitis syndrome; Fc RI; Monocytes; Tacrolimus; TARC

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; TACROLIMUS; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; ATOPIC DERMATITIS; BLOOD; BLOOD SAMPLING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMORAL IMMUNITY; MALE; MONOCYTE; OINTMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT PLANNING;

ADULT; ANTIGENS, CD; CHEMOKINES, CC; DERMATITIS; FEMALE; HUMANS; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; PSORIASIS; RECEPTORS, IGE; SEVERITY OF ILLNESS INDEX; SYNDROME; TIME FACTORS;

EID: 0036786907     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.23737.x     Document Type: Article

References (29)

1. ELIAS JA, SCHREIBER AD, GUSTILO K et al. Differential interleukin-1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol 1985;135:3198-3204.
2. SZABO G, MILLER-GRAZIANO CL, WU JY et al. Differential tumor necrosis factor production by human monocyte subsets. J Leukoc Biol 1990;47:206-216.
3. SZABO G, MILLER CL, KODYS K. Antigen presentation by the CD4 positive monocyte subset. J Leukoc Biol 1990;47:111-120.
4. AKIYAMA Y, STEVENSON GW, SCHLICK E et al. Differential ability of human blood monocyte subsets to release various cytokines. J Leukoc Biol 1985;37:519-530.
5. AKIYAMA Y, MILLER PJ, THURMAN GB et al. Characterization of a human blood monocyte subset with low peroxidase activity. J Clin Invest 1983;72:1093-1105.
6. YASAKA T, MANTICH NM, BOXER LA et al. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol 1981;127:1515-1518.
7. FIGDOR CG, BONT WS, TOUW I et al. Isolation of functionally different human monocytes by counterflow centrifugation elutriation. Blood 1982;60:46-53.
8. CONNOR RI, SHEN L, FANGER MW. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level. J Immunol 1990;145:1483-1489.
9. SZEBERENYI JB, ROTHE G, PALLINGER E et al. Multi-color analysis of monocyte and dendritic cell precursor heterogeneity in whole blood. Immunobiology 2000;202:51-58.
10. GRAGE-GRIEBENOW E, FLAD HD, ERNST M. Heterogeneity of human peripheral blood monocyte subsets. J Leukoc Biol 2001;69:11-20.
11. GRAGE-GRIEBENOW E, FLAD HD, ERNST M et al. Human MO subsets as defined by expression of CD64 and CD16 differ in phagocytic activity and generation of oxygen intermediates. Immunobiology 2000;202:42-50.
12. HUBL W, ZIEGLER-HEITBROCK LH, BAYER PM. A simple method for measurement of CD14weak CD16strong monocytes in peripheral blood. Immunobiology 2000;202:2-10.
13. GRAGE-GRIEBENOW E, ZAWATZKY R, KAHLERT H et al. Identification of a novel dendritic cell-like subset of CD64 (+) / CD16 (+) blood monocytes. Eur J Immunol 2001;31:48-56.
14. FERNANDEZ RC, LEE SH, FERNANDEZ LA et al. Production of interferon by peripheral blood mononuclear cells from normal individuals and patients with chronic lymphocytic leukemia. J Interferon Res 1986;6:573-580.
15. HANIFIN JM, RAJKA O. Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980;92:44-47.
16. JOHANSSON SGO, HOURIHANE JO'B, BOUSQUET J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
17. HANIFIN JM, THURSTON M, OMOTO M et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 2001;10:11-18.
18. KAKINUMA T, NAKAMURA K, WAKUGAWA M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001;107:535-541.
19. NOVAK N, BIEBER T, KATOH N. Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol 2001;167: 797-804.
20. THOMAS R, LIPSKY PE. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. J Immunol 1994;153:4016-4028.
21. ZHENG M, MROWIETZ U. Phenotypic differences between human blood monocyte subpopulations in psoriasis and atopic dermatitis. J Dermatol 1997;24:370-378.
22. CHAN SC, KIM JW, HENDERSON WR Jr, HANIFIN JM. Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol 1993;151:3345-3352.
23. SNIJDERS A, VAN DER POUW KRAAN TC, ENGEL M et al. Enhanced prostaglandin E2 production by monocytes in atopic dermatitis (AD) is not accompanied by enhanced production of IL-6, IL-10 or IL-12. Clin Exp Immunol 1998;111:472-476.
24. WEINER LM, LI W, HOLMES M et al. Phase I trial of recombinant macrophage colony- stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994;54:4084-4090.
25. SCHMID I, BALDWIN GC, JACOBS EL et al. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF. Cytometry 1995;22:103-110.
26. WEINER LM, LI W, HOLMES M et al. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects. Cancer Res 1994;54:4084-4090.
27. WOLLENBERG A, WEN S, BIEBER T. Langerhans cell phenotyping: a new tool for differential diagnosis of inflammatory skin diseases. Lancet 1995;346:1626-1627.
28. PANHANS-GROß A, NOVAK N, KRAFT S, BIEBER T. Human epidermal Langerhans' cells are targets for the immunsuppressive macrolide tacrolimus (FK 506). J Allergy Clinic Immunol 2001;107:345-352.
29. WOLLENBERG A, SHARMA S, VON BUBNOFF D, GEIGER E, HABERSTOK J, BIEBER T. Topical tacrolimus (FK 506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clinic Immunol 2001;107:519-525.